[{"NetIncomeLoss_3_Q3_USD":-87074000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-4286000.0,"OtherAssetsNoncurrent_0_Q3_USD":2727000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":171452000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":26994000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":621372000.0,"Liabilities_0_Q3_USD":230222000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-192000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":37624000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":38081000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermCapitalLeaseObligations_3_Q3_USD":80000000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-21509000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":3444000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":245000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":61390000.0,"ProceedsFromSaleOfShortTermInvestments_3_Q3_USD":17218000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":286971000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":66107000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":20474000.0,"ContractWithCustomerLiability_0_Q3_USD":6700000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":230000000.0,"PaymentsToAcquireAvailableForSaleSecurities_3_Q3_USD":38804000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3429000.0,"CommonStockSharesIssued_0_Q3_shares":38300000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":14551000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-86974000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_3_Q3_USD":2012000.0,"IncreaseDecreaseInInventories_3_Q3_USD":6792000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":89784000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":67000.0,"InventoryWriteDown_3_Q3_USD":15000.0,"PaymentsOfFinancingCosts_3_Q3_USD":7403000.0,"AssetsFairValueDisclosure_0_Q3_USD":221440000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-1533000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-7143000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1116000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":159000.0,"AccountsReceivableNetCurrent_0_Q3_USD":25758000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":200000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":71000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":150000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":1739000.0,"CommonStockValue_0_Q3_USD":4000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":4301000.0,"ContractWithCustomerAssetNet_0_Q3_USD":0.0,"InvestmentIncomeInvestmentExpense_3_Q3_USD":11153000.0,"InvestmentIncomeInvestmentExpense_1_Q3_USD":4154000.0,"RevenueRemainingPerformanceObligation_0_Q3_USD":500000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-2366000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":151744000.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":60036000.0,"CostsAndExpenses_3_Q3_USD":150032000.0,"CostsAndExpenses_1_Q3_USD":49429000.0,"DeferredRevenueNoncurrent_0_Q3_USD":1148000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":5986000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":14993000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":59574000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-193000.0,"CommonStockSharesOutstanding_0_Q3_shares":38300000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":11000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":245000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q3_USD":169964000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-86874000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-21246000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4920000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-70782000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":5622000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":59574000.0,"CostOfRevenue_3_Q3_USD":35691000.0,"CostOfRevenue_1_Q3_USD":13962000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-1390000.0,"LiabilitiesCurrent_0_Q3_USD":32116000.0,"AccountsPayableCurrent_0_Q3_USD":3753000.0,"NonoperatingIncomeExpense_3_Q3_USD":-17896000.0,"NonoperatingIncomeExpense_1_Q3_USD":-3662000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":171452000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":2190000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4028000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":13077000.0,"PaymentsOfDebtExtinguishmentCosts_3_Q3_USD":4845000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1068000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":20856000.0,"NetIncomeLoss_1_Q3_USD":-21317000.0,"DeferredRevenueCurrent_0_Q3_USD":5564000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":142352000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-519026000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":59329000.0,"GainLossOnSaleOfInvestments_3_Q3_USD":-300000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":22263000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-4663000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":81054000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":31845000.0,"OperatingIncomeLoss_3_Q3_USD":-68978000.0,"OperatingIncomeLoss_1_Q3_USD":-17584000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":59574000.0,"InventoryNet_0_Q3_USD":26159000.0,"InvestmentIncomeInterest_3_Q3_USD":1516000.0,"InvestmentIncomeInterest_1_Q3_USD":333000.0,"PreferredStockValue_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":332817000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":13476000.0,"PreferredStockSharesAuthorized_0_Q3_shares":15000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13077000.0,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":737000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4402000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":524000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.31,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.56,"StockholdersEquity_0_Q3_USD":102595000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6808000.0,"Assets_0_Q3_USD":332817000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":48234000.0,"Ticker":"NSTG","CIK":"1401708","name":"NANOSTRING TECHNOLOGIES INC","OfficialName":"NanoString Technologies Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"995164151.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]